Deep-pocketed investors have adopted a bullish approach towards GSK GSK, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GSK usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for GSK. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 50% bearish. Among these notable options, 6 are puts, totaling $198,084, and 2 are calls, amounting to $67,840.
Projected Price Targets
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $38.0 to $43.0 for GSK over the recent three months.
Analyzing Volume & Open Interest
In today's trading context, the average open interest for options of GSK stands at 471.5, with a total volume reaching 7,868.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in GSK, situated within the strike price corridor from $38.0 to $43.0, throughout the last 30 days.
GSK Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| GSK | PUT | SWEEP | BULLISH | 05/17/24 | $40.00 | $44.7K | 79 | 247 |
| GSK | PUT | TRADE | BULLISH | 05/17/24 | $43.00 | $41.7K | 1 | 116 |
| GSK | CALL | SWEEP | BEARISH | 02/16/24 | $38.00 | $37.1K | 1.7K | 1 |
| GSK | CALL | TRADE | BEARISH | 02/16/24 | $38.00 | $30.7K | 1.7K | 263 |
| GSK | PUT | SWEEP | BULLISH | 02/16/24 | $40.00 | $30.6K | 60 | 2.6K |
About GSK
In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Present Market Standing of GSK
- Currently trading with a volume of 2,056,593, the GSK's price is up by 0.71%, now at $39.92.
- RSI readings suggest the stock is currently may be overbought.
- Anticipated earnings release is in 22 days.
What Analysts Are Saying About GSK
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $48.0.
- An analyst from Jefferies has elevated its stance to Buy, setting a new price target at $48.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for GSK, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
